Maud D’Aveni

856 total citations
23 papers, 278 citations indexed

About

Maud D’Aveni is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Maud D’Aveni has authored 23 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Maud D’Aveni's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (4 papers) and Immune Cell Function and Interaction (4 papers). Maud D’Aveni is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (4 papers) and Immune Cell Function and Interaction (4 papers). Maud D’Aveni collaborates with scholars based in France, United States and United Kingdom. Maud D’Aveni's co-authors include Marie‐Thérèse Rubio, Olivier Hermine, Julien Rossignol, Téreza Coman, Marie Thérèse Rubio, Rabah Redjoul, Catherine Cordonnier, Ana Berceanu, Patrice Céballos and Christine Robin and has published in prestigious journals such as Nature Communications, Blood and Science Translational Medicine.

In The Last Decade

Maud D’Aveni

22 papers receiving 277 citations

Peers

Countries citing papers authored by Maud D’Aveni

Since Specialization

Citations

This map shows the geographic impact of Maud D’Aveni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud D’Aveni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud D’Aveni more than expected).

Fields of papers citing papers by Maud D’Aveni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maud D’Aveni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud D’Aveni. The network helps show where Maud D’Aveni may publish in the future.

Co-authorship network of co-authors of Maud D’Aveni

This figure shows the co-authorship network connecting the top 25 collaborators of Maud D’Aveni. A scholar is included among the top collaborators of Maud D’Aveni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maud D’Aveni. Maud D’Aveni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study 2024 ·Blood ·Lionel Adès, Thomas Cluzeau, Thibault Comont, (unknown), Aspasia Stamatoullas, (unknown), Emmanuel Gyan, Alice Garnier, Maud D’Aveni, Sylvain Thépot, Marie Sébert, (unknown), Anouk Walter‐Petrich, (unknown), Fatiha Chermat, Michaëla Fontenay, Sylvie Chevret, (unknown)	3
2	Current challenges in conditioning regimens for MDS transplantation 2024 ·Blood Reviews ·(unknown), Marie Robin, Maud D’Aveni	1
3	Fludarabine and Treosulfan Conditioning Is Feasible and Leads to High OS and Low NRM 2024 ·Blood ·(unknown), Stéphane Morisset, Amandine Pradier, Anne‐Claire Mamez, Federica Giannotti, (unknown), (unknown), Gabrielle Roth-Guépin, Maud D’Aveni, (unknown), (unknown), Federico Simonetta, Simona Pagliuca, Yves Chalandon, Marie‐Thérèse Rubio	0
4	A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic 2023 ·Cytotherapy ·(unknown), Nathalie Thilly, (unknown), Amandine Luc, Véronique Latger‐Cannard, Valérie Eschwège, Danièle Bensoussan, Cécile Pochon, (unknown), Marie‐Thérèse Rubio, Maud D’Aveni, Véronique Decot	1
5	Age‐related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation 2023 ·British Journal of Haematology ·(unknown), Cécile Pochon, (unknown), Maud D’Aveni, (unknown), (unknown), (unknown), (unknown), Pierre Feugier, Pascal Chastagner, Cyril Schweitzer, Manoel de Carvalho, Marie Thérèse Rubio, Simona Pagliuca	2
6	Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation 2023 ·Nature Communications ·Simona Pagliuca, Carmelo Gurnari, (unknown), Sébastien Hergalant, Sanghee Hong, (unknown), Maud D’Aveni, (unknown), Marie Thérèse Rubio, Pierre Feugier, Francesca Ferraro, Hetty E. Carraway, Ronald Sobecks, Betty K. Hamilton, Navneet S. Majhail, Valeria Visconte, Jaroslaw P. Maciejewski	21
7	Senescence and Mitochondrial Transfer Ability of Bone Marrow Mesenchymal Stromal Cells Influence Patterns of Alloreactivity after Allogeneic Hematopoietic Stem Cell Transplantation 2023 ·Blood ·(unknown), (unknown), (unknown), (unknown), Cécile Pochon, Maud D’Aveni, Simona Pagliuca, Marie‐Thérèse Rubio, N. de Isla	1
8	Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation 2023 ·Leukemia & lymphoma ·(unknown), Cédric Baumann, Hélène Rousseau, (unknown), Marie‐Thérèse Rubio, Maud D’Aveni	1
9	Allogeneic stem cell transplantation-A curative treatment for paroxysmal nocturnal hemoglobinuria with PIGT mutation: A case report 2022 ·World Journal of Clinical Cases ·(unknown), (unknown), Véronique Latger‐Cannard, Véronique Frémeaux‐Bacchi, Manoel de Carvalho, Marie‐Thérèse Rubio, Marc Müller, Maud D’Aveni	4
10	Allogeneic Stem Cell Transplant for Myelodysplastic Syndrome in the New Molecular Era of IPSS-M 2022 ·Blood ·Carmelo Gurnari, Nico Gagelmann, Anita Badbaran, Hussein Awada, Danai Dima, Simona Pagliuca, Maud D’Aveni, (unknown), Raffaella Cerretti, Christine Wolschke, Marie Thérèse Rubio, Jaroslaw P. Maciejewski, Nicolaus Kröger	1
11	On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation 2021 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Marie Robin, Thomas Rémen, Amandine Luc, Hélène Labussière‐Wallet, (unknown), Micha Srour, Patrice Céballos, Édouard Forcade, (unknown), Sabine Fürst, Pascal Turlure, Jacques‐Olivier Bay, Célestine Simand, Ambroise Marçais, Étienne Daguindau, Marie‐Thérèse Rubio, Maud D’Aveni	3
12	Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program 2020 ·Biology of Blood and Marrow Transplantation ·Christine Robin, Anne Thiébaut, Sophie Alain, Flore Sicre de Fontbrune, Ana Berceanu, Maud D’Aveni, Patrice Céballos, Rabah Redjoul, (unknown), (unknown), (unknown), Catherine Cordonnier	54
13	Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation 2020 ·Frontiers in Immunology ·Maud D’Aveni, (unknown), (unknown), (unknown), Cécile Pochon, Marie Thérèse Rubio	22
14	Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and a review of the literature 2019 ·Haematologica ·Nicolas Gendron, Flore Sicre de Fontbrune, Alice Guyard, Jehane Fadlallah, Sylvain Chantepie, Maud D’Aveni, Ronan Le Calloch, Alice Garnier, (unknown), (unknown), (unknown), Louis Terriou, Estibaliz Lazaro, Gèrard Socié, Régis Peffault de Latour	6
15	Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies 2018 ·Journal of Clinical Immunology ·Jérôme Hadjadj, Aurélien Guffroy, (unknown), Guillaume Taïeb, Isabelle Meyts, A. Frésard, Nathalie Streichenberger, Anne-Sophie L’Honneur, Flore Rozenberg, Maud D’Aveni, Claire Aguilar, Jérémie Rosain, Capucine Pïcard, Nizar Mahlaoui, Marc Lecuit, Olivier Hermine, Olivier Lortholary, Felipe Suárez	14
16	Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study 2018 ·Cytotherapy ·(unknown), Chongsheng Qian, (unknown), Véronique Decot, Loïc Reppel, Maud D’Aveni, Danièle Bensoussan	3
17	Update on Actinomucor elegans , a mucormycete infrequently detected in human specimens: how combined microbiological tools contribute efficiently to a more accurate medical care 2017 ·International Journal of Medical Microbiology ·(unknown), Maud D’Aveni, Anne Debourgogne, Michael F. Cuenin, (unknown), (unknown), P. Gallet, (unknown), Marie Machouart	5
18	G-CSF mobilizes CD34 ⁺ regulatory monocytes that inhibit graft-versus-host disease 2015 ·Science Translational Medicine ·Maud D’Aveni, Julien Rossignol, Téreza Coman, (unknown), Stephen Henderson, Teresa Manzo, Pedro Santos e Sousa, Julie Bruneau, Guillemette Fouquet, Flora Zavala, Olinda Alegria-Prévot, Meriem Garfa‐Traoré, Felipe Suárez, Hélène Trebeden‐Negre, Mohamad Mohty, Clare L. Bennett, Ronjon Chakraverty, Olivier Hermine, Marie‐Thérèse Rubio	67
19	Depletion of CD11c⁺ cells in the CD11c.DTR model drives expansion of unique CD64⁺ Ly6C⁺ monocytes that are poised to release TNF‐α 2015 ·European Journal of Immunology ·(unknown), Stephen Henderson, Sophie Ward, Pedro Santos e Sousa, Teresa Manzo, Lei Zhang, (unknown), Terry K. Means, Maud D’Aveni, Olivier Hermine, Marie‐Thérèse Rubio, Ronjon Chakraverty, Clare L. Bennett	10
20	The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation 2011 ·Transplant Immunology ·Maud D’Aveni, (unknown), Véronique Venard, Alexandra Salmon, (unknown), Véronique Decot, J.-M. Virion, Yingying Wang, Laurence Clément, Véronique Latger‐Cannard, Cécile Tomowiak, J.F. Stoltz, Pierre Bordigoni, Danièle Bensoussan	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact